Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
THE PHARMACEUTICAL INDUSTRY, For consumers, a bitter pill to swallow, How did it become so easy for the drug companies to market their goods? Ask the courts, then the FDA
by
GREG CRITSER. Greg Critser, author of "Fat Land: How Americans Became the Fattest People in the World" is writing a book about the pharmaceutical industry. This is from the Los Angeles Times
2004
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
THE PHARMACEUTICAL INDUSTRY, For consumers, a bitter pill to swallow, How did it become so easy for the drug companies to market their goods? Ask the courts, then the FDA
by
GREG CRITSER. Greg Critser, author of "Fat Land: How Americans Became the Fattest People in the World" is writing a book about the pharmaceutical industry. This is from the Los Angeles Times
in
2004
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
THE PHARMACEUTICAL INDUSTRY, For consumers, a bitter pill to swallow, How did it become so easy for the drug companies to market their goods? Ask the courts, then the FDA
by
GREG CRITSER. Greg Critser, author of "Fat Land: How Americans Became the Fattest People in the World" is writing a book about the pharmaceutical industry. This is from the Los Angeles Times
2004
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
THE PHARMACEUTICAL INDUSTRY, For consumers, a bitter pill to swallow, How did it become so easy for the drug companies to market their goods? Ask the courts, then the FDA
Newspaper Article
THE PHARMACEUTICAL INDUSTRY, For consumers, a bitter pill to swallow, How did it become so easy for the drug companies to market their goods? Ask the courts, then the FDA
2004
Request Book From Autostore
and Choose the Collection Method
Overview
Liberals and consumer activists might be surprised to learn that a series of court cases initiated by Ralph Nader in the 1970s gave rise to today's reigning legal notions about commercial speech, which supply the legal framework for such things as off-label promotion of drugs (the marketing to doctors of medications for uses other than those approved by the FDA) and direct-to-consumer advertising of prescription drugs. Should a drug company be able to distribute, via highly trained and restrained medical affairs people, studies showing that a drug approved for one purpose also \"seems\" to help kids with, say, end- stage brain cancer, an unapproved use? The average consumer would probably say yes. But the waters quickly get muddier. Should a drug company be allowed, as has been the case with antidepressants, to dispatch tens of thousands of young, barely trained sales reps to give general practitioners studies that \"suggest\" that adult antidepressants \"might\" help kids with depression? The FDA's traditional response was to come down hard on the latter but not on the former, and most of us would be likely to agree with that inclination. The FDA's tolerance of drug company product promotion reached new heights under Bush appointee Mark McClellan, until March the agency's chief. McClellan made clear to the pharmaceutical industry immediately after his appointment that he intended to change the FDA's image. Under him, that image morphed from one of a tough, independent-minded regulatory body to a partner in nurturing pharmaceutical innovation. In Medical Marketing & Media, McClellan could be found with Peter Pitts, his then-new public affairs director, alongside the headline, \"We won't bite.\"
Publisher
Newsday LLC
MBRLCatalogueRelatedBooks
Related Items
Related Items
We currently cannot retrieve any items related to this title. Kindly check back at a later time.
This website uses cookies to ensure you get the best experience on our website.